Read The Pathological Role of A-Fabp in the Development of Liver Fibrosis - Xiaohui Xu | ePub
Related searches:
Adiponectin and adipocyte fatty acid binding protein in the
The Pathological Role of A-Fabp in the Development of Liver Fibrosis
The pathological role of A-FABP in the development of - CORE
Shu LINGLING Doctor of Philosophy The University of Hong
2880 3016 4430 4601 4888 4632 2517 3408 3008 1823 4165 999 4731 2909 4332 339 3428
What is ftd? it's the most common dementia for those under 60, yet it's widely misunderstood and too often misdiagnosed.
We investigated the role of adipocyte fabp and epithelial fabp in the development of experimental autoimmune encephalomyelitis to test the hypothesis that.
The present study demonstrates that elevated a-fabp expression in kupffer cells is accompanied by its increased infiltration and augmented production of pro-inflammatory cytokines in the liver tissue of both lps-treated mice and diet-induced obese mice, whereas pharmacological inhibition of a-fabp by bms309403 reverses these pathological.
(a-fabp) expression was associated with bladder cancer progres-sion. A-fabp is a lipid binding protein playing a role in intracellu-lar lipid transport and metabolism, as well as in signal transduc-tion. We reported from bladder tumors that decrease of a-fabp transcript level significantly correlated to tumor stage and to histo-.
A-fabp, afabp, fatty acid binding protein (adipocyte), adipocyte lipid-binding protein, albp, adipocyte-type fatty search our catalog.
Thus, a-fabp in macrophages and adipocytes has pathological effects on vessels. In humans, cohort studies suggested that a-fabp plays an important role in insulin resistance and metabolic syndrome. Our study shows that diabetic patients over the medium level of plasma a-fabp had a significantly greater presence of cad than diabetic patients.
Adipocyte fatty acid-binding protein (a-fabp) is up-regulated in regenerated endothelial cells and modulates inflammatory responses in macrophages.
Lipotoxicity is implicated in the pathogenesis of obesity-related inflammatory complications by promoting macrophage infiltration and activation.
Accumulating evidence of the causative role of a-fabp in cardiometabolic syndrome indicates that a-fabp is a novel target for the prevention of adiposopathy-induced mets and cvd arterial stiffness, a pathological condition with unregulated elastin fiber and collagen accompanied with low-grade inflammation, reflects vascular and subclinical organ damage and is now recognized as a surrogate marker for cvd [10].
The role of a-fabp in the pathogenesis of cerebral ischemic stroke the role of mitochondrial membrane protein chchd10 in the regulation of adipose tissue browning and energy expenditure the role of neutrophil and its secretory proteases in the conversion of white to brown adipocytes.
Tubulointerstitial and glomerular injuries have important roles in the pathogenesis of diabetic nephropathy several recent studies demonstrated that urinary tubular damage markers, such as kim-1, ngal and l-fabp, may have the potential to be clinical markers for identifying the development or progression of diabetic nephropathy [27] – [30].
Mar 5, 2021 complete information for fabp4 gene (protein coding), fatty acid binding protein 4, including: function, proteins, disorders, pathways,.
However, the precise role of a-fabp in the pathogenesis of obesity-related chronic liver diseases remains unclear. In the present study, we provided both ex vivo and in vivo evidence demonstrating increased a-fabp expression in kcs to be an important mediator of both endotoxin-induced acute liver injury and obesity-related nafld. We also explored the therapeutic potential of the a-fabp inhibitor bms309403 in the treatment of both acute and chronic liver injuries in mice.
Endoplasmic reticulum (er) stress and adipocyte fatty acid binding protein (a-fabp) play key roles in obesity and mediate inflammatory activity through similar signaling pathways.
A-fabp antibody (b-4) is a monoclonal anti-fabp4 antibody that detects m, r, and an integral role in the balance between lipid and carbohydrate metabolism.
Mar 19, 2021 this review will discuss recent findings on the role of afabp in cvd and with chronic nutrient excess, pathological expansion of the adipose.
Fatty acid binding protein 4 (fabp4), also known as a-fabp and ap2, is the predominant fabp found in adipocytes and is often used as a marker for adipocyte.
Circulating adipose fatty acid binding protein (a-fabp) promotes obesity-associated breast cancer development. A-fabp released by adipose tissue directly targeted mammary tumor cells, enhancing tumor stemness and aggressiveness through activation of the il-6/stat3/aldh1 pathway.
Adipocyte fatty acid-binding protein (a-fabp, also referred to as fabp4, ap2) is highly expressed in adipocytes and macrophages and is extensively involved in inflammation and glucose and lipid metabolism. Intermittent high glucose exacerbates a-fabp activation and inflammatory response through tlr4-jnk signaling in thp-1 cells.
Oct 29, 2012 here, we investigated the role of a-fabp in both lipopolysaccaride (lps)- induced acute liver injury and high fat high cholesterol (hfhc).
Oct 28, 2011 background adipocyte fatty acid-binding protein (a-fabp) has been shown to play important roles in the development of metabolic syndrome,.
Adipose tissue plays a key role in the develop- ment of insulin resistance and its pathological squealed, such as type 2 diabetes, mets and non- alcoholic fatty liver.
Thus, a-fabp in macrophages and adipocytes has pathological effects on vessels. In humans, cohort studies suggested that a-fabp plays an important role in insulin resistance and metabolic syndrome. Our study shows that diabetic patients over the medium level of plasma a-fabp had a significantly greater presence of cad than diabetic patients with lower plasma a-fabp.
Abstract background: adipocyte fatty acid-binding protein (a-fabp) has been recognized as an important player in macrophage cholesterol trafficking and inflammation, and may promote the development of atherosclerosis.
A-fabp (fabp4) is detected especially in adipose tissue and cytoplasm of macrophages. Animal studies describe its possible role in insulin resistance development. Higher plasmatic levels are reffered in obese, in female and patients with metabolic syndrome.
While a-fabp was initially described in adipocytes and macrophages, the expression of this protein has currently been demonstrated in different cell types and in particular in some tumours. It could act either as a tumour suppressor or as an oncogene depending on tumour type.
Epidemiological studies demonstrate a close association between serum levels of a-fabp and a cluster of obesity-related cardio-metabolic risk factors, endothelial dysfunction, and macrovascular complications of diabetes. First, circulating levels of a-fabp are closely correlated with several key features of the metabolic syndrome, including adverse lipid profiles (increased serum triglyceride and ldl-cholesterol, and decreased hdl-cholesterol), hyperglycemia, and hypertension, independently.
May 23, 2011 adipocyte fatty acid-binding protein (a-fabp) has been reported to play critical roles in the development of atherosclerosis.
Background and objectives: circulating levels of adipocyte fatty acid binding protein (a-fabp) are closely associated with liver fibrosis and inflammation in patients with nonalcoholic fatty liver disease (nafld). However, there are no in vivo studies to explore the role of a-fabp in liver fibrosis.
Oct 18, 2017 here we investigated the pathological role of a-fabp in the development of renal dysfunction associating with obesity.
These properties of h-fabp might help to understand the pathological process of ami in a more comprehensive way and hopefully also help to guide the diagnosis as well as treatment.
Fatty acid-binding protein (fabp) functions as a long-chain fatty acid carrier in blood. The heart type isoenzyme is found in the heart and skeletal muscles.
Post Your Comments: